Member Info for Timster

YOU are so wise oh great one....

if you want to know what Smith actually says about BAMS

https://youtu.be/Pgmvuj86VcA?t=2971

Being evaluated by Bruker but on the back burner as per the last interview. Resources all concentrating on bringing the LFT to market

Does seem the media machine is on the move to discredit Innova, they've even finally discovered its Chinese.

Make way for the Sovereign test.....

So after todays update we know Smith can sway Massive Global companies to take on Affimer based products. This is another massive endorsement of the platform.

It also makes this statement in the business update even more intersting:

"Avacta will immediately be able access initial manufacturing capacity through Mologic, in addition to scale-up manufacturing capacity with BBI and Abingdon Health. Combined, these manufacturing partnerships can scale up to several million tests per month and potentially much higher with further investment. Avacta is also continuing its discussions with other manufacturers in the UK and overseas in order to be able to access additional capacity to ensure that it can meet the expected demand.



The Group continues its commercial discussions with potential customers for the AffiDX® SARS-CoV-2 Lateral Flow Rapid Antigen Test and expects demand to be present for rapid testing for at least two years and probably for longer. Only by having a high-quality test that identifies the majority of infectious individuals can this clinical need be translated into commercial success and the Group believes that the recent initial clinical data are extremely encouraging in that regard."

I wonder when we will hear who the "overseas" manufacturers will be? We know the the far east have massive capacity, Innova can do 15 million a day! Mind you I'd rather not have a made in china AffiDX but business is business.

He's an avacta investor Maaat he said so :)

Tsales do you have any understanding on how ODX business model works and GAD. Which test they might be waiting for? I'll give you a clue from a recent avacta RNS on a partnership with Mologic:

The partnership also immediately provides Avacta with additional manufacturing capacity through Mologic and its partners including Global Access Diagnostics (GAD)

To save you clicking the link:

Collaborations
The COVID-19 crisis has brought together the scientific community like never before. Our global team is helping to accelerate the work of researchers, developers, and manufacturers of diagnostics and vaccines, to bring access to much-needed solutions for COVID-19.

Genedrive: PCR assay to detect SARS-CoV-2
Sona Nanotech: rapid response lateral flow test
Avacta: Affimer-based point-of-care rapid screening test
Entos Pharmaceuticals: downstream purification method for protein-based vaccine
Takara Bio: plasmid vaccine
Aptamer Group: rapid response lateral flow test

That establishing a global route to market for the SARS-CoV-2 spike protein affimer reagents through ABCAM's dedicated global commercialisation infrastructure is seen as a good thing. Smith pulls another great deal out the bag.

yep HL seems to be screwed again like it was a few months back

I wonder if they would add a world beating LFT to a the catalogue. They have some antibody detection kits at the moment.

Let's be honest ELISA sales are not in the billions maybe even not in the millions but it show cases the best of its kind and that's an Affimer

We have a Chinese trademark don't forget £600 inc china

Not sure this got missed earlier but 80% of 37bn for testing !!!!... that's a lot!!

Jealousy is a terrible thing trendz

Agreed agent, and I think maaat's posts over the last few days make a lot of sense, stuff bojo and sell for a higher price elsewhere

Definately innova from Friday, I'm taking from this.
Then we will take over and also rule the world....

Are you not extremely concerned and a bit anxious oldtrader. No point lying to us we know you are

He didn't say Avacta. 50p tomorow

Smith will be up soon in matching union Jack shumpers. What a way to open up the new press room

But you must be at least a bit concerned RNmyS?